Milbank LLP represented Goldman Sachs Merchant Banking Division and Tikehau Investment Management, as joint lead arrangers in the financing of Warburg Pincus and ArchiMed’s acquisition of Polyplus-transfection® SA (“Polyplus”).
Polyplus is a French biotechnology company that specializes in the development and sale of solutions for the delivery of nucleic acids in research, bioproduction and therapeutics.
The Milbank team was led by Global Leveraged Finance partners Marcus Dougherty, Lauren Hanrahan and Sarbajeet Nag and associates Morgan Lingar, Joy-Annette Atsegbua and Stephanie Colquhoun. Tax partner Eschi Rahimi-Laridjani and associate Archan Hazra also provided advice on various points in the transaction.
